a244 rgp120/hiv-1
Vaccineexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Mar 1, 1999 (NCT00006327)
Timeline
Indications
Mechanism of action
- GP41Immunity, active
HIV1 ENV immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- a244 rgp120/hiv-1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04658667 | Phase 1 | Aug 31, 2021 | Government of Thailand, Mahidol University, United States Army |
| NCT00002402 | Phase 1 | Nov 2, 1999 | VaxGen |
| NCT00006327 | Phase 3 | Mar 1, 1999 | VaxGen |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| VaxGen | For profit | 2 | 2 | 2 | 1999 |
| Government of Thailand | Government | 1 | 0 | 1 | 2021 |
| Mahidol University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| United States Army | Government | 1 | 1 | 1 | 2021 |
4 organizations
Page 1 / 1